Sectors
TNDM
Tandem Diabetes Care, Inc.
22.70
3 x 22.54
1 x 22.58
bid
ask
-
0.11
0.48%
09:41 AM
timesize
| Ytd | 3.28% | |
| 1y | 124.53% |
22.56
day range
23.00
10.25
52 week range
29.65
| Open | 22.61 | Prev Close | 22.81 | Low | 22.56 | High | 23.00 | Mkt Cap | 1.55B |
| Vol | 75.16K | Avg Vol | 2.42M | EPS | -1.10 | P/E | -20.61 | Forward P/E | 133.98 |
| Beta | 1.54 | Short Ratio | 6.90 | Inst. Own | 116.38% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 17.16 | 200-d Avg | 19.18 | 1yr Est | 28.55 |
| Income Statement | |||
| Total Revenue | 254.56M | ||
| Revenues (USD) | 254.56M | ||
| Cost of Revenue | 109.78M | ||
| Gross Profit | 144.78M | ||
| Operating Expenses | 158.57M | ||
| Research and Development Expense | 46.93M | ||
| Selling, General and Administrative Expense | 111.64M | ||
| Operating Income | -13.79M | ||
| Interest Expense | 2.45M | ||
| Income Tax Expense | 510.00K | ||
| Net Income | -21.17M | ||
| Net Income Common Stock | -21.17M | ||
| Net Income Common Stock (USD) | -21.17M | ||
| Consolidated Income | -21.17M | ||
| Earnings per Basic Share | -0.31 | ||
| Earnings per Basic Share (USD) | -0.31 | ||
| Earnings per Diluted Share | -0.31 | ||
| Earning Before Interest & Taxes (EBIT) | -18.21M | ||
| Earning Before Interest & Taxes (USD) | -18.21M | ||
| Weighted Average Shares | 69.01M | ||
| Weighted Average Shares Diluted | 69.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 62.82M | ||
| Cash and Equivalents (USD) | 62.82M | ||
| Investments | 525.45M | ||
| Investments Current | 393.18M | ||
| Investments Non-Current | 132.27M | ||
| Trade and Non-Trade Receivables | 162.07M | ||
| Current Assets | 804.64M | ||
| Property, Plant & Equipment Net | 184.69M | ||
| Total Assets | 1.15B | ||
| Debt Current | 20.27M | ||
| Total Debt | 739.25M | ||
| Current Liabilities | 253.01M | ||
| Debt Non-Current | 718.99M | ||
| Total Liabilities | 1.02B | ||
| Accumulated Retained Earnings (Deficit) | -1.29B | ||
| Accumulated Other Comprehensive Income | 6.40M | ||
| Shareholders Equity | 130.39M | ||
| Shareholders Equity (USD) | 130.39M | ||
| Assets Non-Current | 349.56M | ||
| Total Debt (USD) | 739.25M | ||
| Deferred Revenue | 16.21M | ||
| Inventory | 135.11M | ||
| Liabilities Non-Current | 770.81M | ||
| Trade and Non-Trade Payables | 64.13M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.47M | ||
| Net Cash Flow from Financing | 2.15M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -116.51M | ||
| Capital Expenditure | -4.05M | ||
| Net Cash Flow from Investing | -87.34M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -83.29M | ||
| Net Cash Flow from Operations | -34.63M | ||
| Effect of Exchange Rate Changes on Cash | 3.31M | ||
| Share Based Compensation | 15.74M | ||